Hologic, Inc (NASDAQ: HOLX) on Tuesday, plunged -0.92% from the previous trading day, before settling in for the closing price of $79.73. Within the past 52 weeks, HOLX’s price has moved between $67.59 and $84.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 6.10%. The company achieved an average annual earnings per share of 5.48%. With a float of $229.03 million, this company’s outstanding shares have now reached $241.71 million.
Considering the fact that the conglomerate employs 6990 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 55.98%, operating margin of 23.21%, and the pretax margin is 21.47%.
Hologic, Inc (HOLX) Insider Activity
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Hologic, Inc is 1.40%, while institutional ownership is 101.16%. The most recent insider transaction that took place on Aug 29 ’24, was worth 4,243,662. In this transaction Chief Financial Officer of this company sold 52,679 shares at a rate of $80.56, taking the stock ownership to the 84,042 shares. Before that another transaction happened on Aug 29 ’24, when Company’s Officer proposed sale 52,679 for $80.56, making the entire transaction worth $4,243,657.
Hologic, Inc (HOLX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 5.48% per share during the next fiscal year.
Hologic, Inc (NASDAQ: HOLX) Trading Performance Indicators
Hologic, Inc (HOLX) is currently performing well based on its current performance indicators. A quick ratio of 3.03 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.55. Likewise, its price to free cash flow for the trailing twelve months is 15.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.32, a number that is poised to hit 1.02 in the next quarter and is forecasted to reach 4.74 in one year’s time.
Technical Analysis of Hologic, Inc (HOLX)
Compared to the last year’s volume of 1.6 million, its volume of 1.78 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 65.26%. Additionally, its Average True Range was 1.48.
During the past 100 days, Hologic, Inc’s (HOLX) raw stochastic average was set at 47.89%, which indicates a significant increase from 47.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.44% in the past 14 days, which was lower than the 19.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.33, while its 200-day Moving Average is $77.69. Nevertheless, the first resistance level for the watch stands at $79.92 in the near term. At $80.85, the stock is likely to face the second major resistance level. The third major resistance level sits at $81.51. If the price goes on to break the first support level at $78.33, it is likely to go to the next support level at $77.67. Should the price break the second support level, the third support level stands at $76.74.
Hologic, Inc (NASDAQ: HOLX) Key Stats
Market capitalization of the company is 18.35 billion based on 232,272K outstanding shares. Right now, sales total 4,030 M and income totals 789,500 K. The company made 987,900 K in profit during its latest quarter, and 178,600 K in sales during its previous quarter.
